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Exploring the eﬀect of laser excitation wavelength
on signal recovery with deep tissue transmission
Raman spectroscopy†
Adrian Ghita,a Pavel Matousek*b and Nicholas Stone*a
The aim of this research was to ﬁnd the optimal Raman excitation wavelength to attain the largest possible
sensitivity in deep Raman spectroscopy of breast tissue. This involved careful consideration of factors
such as tissue absorption, scattering, ﬂuorescence and instrument response function. The study examined
the tissue absorption proﬁle combined with Raman scattering and detection sensitivity at seven diﬀerent,
laser excitation wavelengths in the near infrared region of the spectrum. Several key scenarios in regards
to the sample position within the tissue were examined. The highest Raman band visibility over the back-
ground ratio in respect to biological tissue provides the necessary information for determining the
optimum laser excitation wavelength for deep tissue analysis using transmission Raman spectroscopy,
including detection of breast calciﬁcations. For thick tissues with a mix of protein and fat, such as breast
tissue, 790–810 nm is concluded to be the optimum excitation wavelength for deep Raman
measurements.
Introduction
Breast cancer represents the most common form of malig-
nancy among women worldwide, with more than half a
million killed by the disease in 2011.1 For early detection of
breast cancers, many national and local healthcare providers
have implemented population-screening programs using a
standard mammographic X-ray imaging technique. The
purpose of the screening programs is to detect breast calcifica-
tions and densities, which can be associated with the presence
of malignancy. Screening detects around 18 000 cancers per
year in the UK out of the 48 000 diagnosed.2 Despite this
success, mammographic imaging lacks the chemical speci-
ficity to establish the true nature of the calcifications identi-
fied, to assist in classification of benign or malignant types.
Furthermore, the sensitivity of mammography is reduced in
dense breasts, presenting a serious problem for those individ-
uals with higher breast density; especially the case among
younger women.3,4 In the absence of an eﬀective chemical
method to provide a definitive answer, the patient undergoes a
biopsy followed by histopathological examination to declare
the final diagnosis. The procedure involves considerable time
delays that can cause substantial anxiety for the patient and
puts considerable burden on health service resources.
Light interaction with biological tissue can result in absorp-
tion, scattering, reflection and refraction. Each one of these
phenomena can be utilised to obtain morphological or chemi-
cal information about the tissue structures. Recently, several
optical methods have been proposed for tissue imaging.
Optical coherence tomography is one example and is based on
light scattering and reflection to produce micrometre-resolu-
tion images of tissue structures.5 Another method, photo-
acoustic tomography proposed for in vivo tissue imaging, uses
the sound-waves generated by the rapid local heating in the
tissue from the laser absorption. This method takes advantage
of the strong absorption of haemoglobin in the NIR domain to
generate high contrast images. Thus strong vascularised struc-
tures like malignant formations are easier to detect inside bio-
logical tissue.6 Another method, diﬀuse optical imaging,
exploits the changes of the transmitted ballistic photon inside
breast tissues.7,8 Despite the fact that all these methods can
bring major improvement in medical imaging, they suﬀer
from delivering limited chemical information required for
complete diagnosis of many abnormalities observed.
There have been early studies using X-ray diﬀraction9–11
performed on breast tissue sections that have revealed
diﬀerent crystalline structures of calcifications, namely the
presence of calcium oxalate and carbonated hydroxyapatite.
Furthermore, the chemical composition of these structures is
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correlated with benign or malignant types of associated
lesions inside breast tissue.10 However, practical implemen-
tation of an in vivo XRD approach is diﬃcult (and uses poten-
tially harmful ionising radiation).
Raman spectroscopy is an analytical technique based on
inelastic scattering of light by the sample molecule and pro-
vides rich chemical information. The idea of using Raman
spectroscopy for biomedical applications has gained consider-
able attraction in the last 25 years12 with recent advances in
instrumental performance and associated detection
sensitivity.13–15 Raman spectroscopy combined with optical
microscopy has opened the door to automated clinical classifi-
cation methods based on chemical specificity of tissue sec-
tions.16 It can be envisaged as an objective pathological tool to
discriminate between tissue sections,17–23 or tissue regions
within the same tissue section by using spectral analysis
methods based on multivariate processing methods.
Raman spectroscopy represents a very versatile tool as it
can be incorporated into an endoscopic probe to provide easy
access to certain biological sites24 or in a hypodermic needle
to identify abnormalities within the injection sites.25
Although, fibre probes have the potential to probe both the
surface of organs and small tissue volumes, when inserted
interstitially, they are invasive and not suitable for examining
large volumes of tissues within solid organs such as in the
breast and prostate.
Application of Raman spectroscopy to large volumes in bio-
logical samples requires an in-depth understanding of the
complexity of absorption and scattering phenomena encoun-
tered when light travels inside a highly heterogeneous matrix
such as breast tissue. The photons travelling inside the tissue
are undergoing multiple scattering processes due to huge vari-
ation in the optical properties between tissue regions, biologi-
cal cells and cell organelles. The multiple scattering events
experienced by the laser and Raman photons impede conven-
tional optical imaging and can severely hamper the detection
eﬃciency of Raman system.
In addition, absorption events even at a wavelength where
tissue absorption is minimised, become very important when
dealing with large tissue samples. Previous Raman spectro-
scopy measurements in turbid media have shown a strong
influence from the absorption coeﬃcient [μa], a drop in the
signal being linearly proportional to 1/μa.26 Consequently, the
laser penetration depth is dependent on the wavelength and
heavily influenced by the absorption profile of specific sample.
Moreover, the fluorescence caused by the various chromo-
phores located inside human tissue can, in some situations,
overwhelm the entire Raman spectrum. One potential solution
to avoid fluorescence and retrieve Raman signals from deeper
layers is the use of the picosecond Kerr gating technique.
Using this approach, Raman signals from calcifications have
been retrieved from depths of 0.9 mm in biological tissue.27
However, since the application itself, utilises high
power pulsed lasers, the suitability for in vivo application
raises questions due to prohibitive costs and laser safety
concerns.
A considerably simpler alternative to Kerr gating is to
recover the Raman spectra from depth by spatial oﬀset Raman
spectroscopy (SORS). This approach involves illuminating the
sample surface at one point and collecting the Raman signal
at diﬀerent spatially oﬀset locations. It provides a high degree
of flexibility as it can probe diﬀerent depths within the sample
just by adjusting the distance between illumination and collec-
tion points.28 In the inverse SORS configuration, a ring illumi-
nation is designed with the collection point in the centre of
the circle.29 What is appealing about this approach is the facil-
ity to accommodate higher laser powers within the safety
limits since the laser light can be spread over the area of the
illumination ring, opening the door to the possibility of in vivo
application of SORS. The SORS configuration can be used to
probe tumours as demonstrated in detecting calcium oxalate
and hydroxyapatite inside chicken breast30 or profile tumour
margins of breast tissue sample with 95% and 100% speci-
ficity.31 Despite the numerous advantages of the SORS con-
figuration, the highest penetration depth reported inside
biological tissue is around 10 mm,32 well below the desired
tissue penetration depth (order of 40–50 mm).
Probing Raman at a deeper level inside large diﬀusely scat-
tering samples has been facilitated using transmission Raman
geometries with non-biological samples in quality control on
pharmaceutical manufacture31 or security.33 The set-up of
Transmission Raman spectroscopy is relatively simple and ver-
satile, dating from the very beginning of the Raman spec-
troscopy.34 Therefore, it seems reasonable to consider the
concept of Transmission Raman spectroscopy for clinical
applications in vivo. The non-invasive approach of Raman
spectroscopy without the need of sample preparation rep-
resents a promising tool for deep tissue detection of breast cal-
cifications, which can be deployed as a complementary
technique to standard mammographic screening. The Raman
spectra of calcium oxalate (type I calcifications) and hydroxy-
apatite (type II calcifications) possess strong sharp features
and can be easily distinguished from the surrounding Raman
bands of biological tissue.35 This strong contrast can be
exploited for detection and typing of breast calcifications on a
reliable basis. The proof of principle of this concept was
demonstrated earlier35 when Raman signals from hydroxy-
apatite powder were recovered from a 26 mm thick block of
porcine tissue. Although the results are promising, further
developments are required for Raman signal acquisition from
within tissues as thick as 50 mm. Deep Raman spectroscopy
has been applied as a tomographic configuration for in vitro
imaging of canine bone36 and in vivo imaging of rat bone37 or
through fibre probes within the surgical environment.38–40
This paper discusses the optimisation of a deep Raman
system by analysing the signal to noise ratio obtained at
several representative laser wavelengths within the NIR spec-
tral domain. The main aim was to identify the optimum
Raman excitation wavelength to inform the next-stage develop-
ment of high sensitivity Raman platform for achieving scan-
ning depths of 4–5 cm with clinically relevant calcification
concentrations in breast tissue in vivo.
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The breast tissue phantoms used in this study were made of
porcine shoulder tissues. These contained skin, fat and
muscle replicating much of the gross chemical composition of
human breast tissue. The tissue samples were purchased fresh
from a local supermarket and sliced to a thickness of around
35 mm × 80 mm × 60 mm (precision of ±3 mm). A quartz
optical vial (dimensions 37 × 12 × 3 mm) filled with trans-stil-
bene [tS] was used as an inorganic marker to simulate distinct
breast calcification signals.
Transmission Raman instrument
The schematics of the transmission Raman set-up is presented
in Fig. 1. The laser used in these experiments was a tuneable
Ti:Sapphire laser 3900S (Newport Spectra Physics, Santa Clara,
US) pumped by a 532 nm Finesse (Laser Quantum, Stockport,
UK). To clean up the laser line spectrally from spurious ampli-
fied spontaneous emission a NIR acousto-optic tuneable filter
(AOTF) was used (Gooch & Housego, Ilminster, UK). After
passing through the AOTF, the laser light was delivered to the
sample with a spot size of 2 mm. The Raman signal was col-
lected on the other side of the sample with a 50 mm diameter
biconvex collection lens with 38.4 mm focal length (N.A. = 0.7).
A de-magnifying optical train was used to match the light path
to the available 25 mm diameter filters used for removing elas-
tically scattered light.
Three edge filters were used for diﬀerent laser excitation
wavelengths as follows: a 785 nm filter (BLP01-785R-25,
Semrock, Rochester, US) for 770 nm, 780 nm and 790 nm; an
808 nm filter (BLP01-808R-25, Semrock, Rochester, US) for
800 nm and 810 nm; and an 830 nm filter (LP02-830RU-25,
Semrock, Rochester, US) for 820 nm and 830 nm.
Finally, an imaging lens channelled the collected Raman
photons into a dispersive spectrometer (Holospec f/1.8 Kaiser
Optical, Michigan, US). The spectrometer was equipped with a
fixed custom-made transmission diﬀraction grating covering a
spectral range from 700 nm to 1100 nm. The spectrometer was
coupled to a deep depletion NIR CCD detector (Andor iDus
420, Oxford Instruments, Belfast, UK). The large spectral range
of the detection system enabled rapid switching between laser
excitation wavelengths and recording the corresponding
Raman fingerprints without a recourse to a major change in
the setup. The estimated spectral resolution of the system,
using the atomic lines of the Ocean Optics calibration source
was around 12 cm−1. The instrument response function of the
system was obtained using an HL-2000 (Ocean Optic) white
light source. The instrument response function was measured
separately for each long pass filter used in the Raman
measurements and includes also intermediary optics.
Experimental methods
The attenuation profile of the phantom tissue was calculated
as the logarithm of the ratio between input light intensity and
output light intensity of spectrally dispersed light. The relative
light intensity was estimated based on the number of counts
recorded by the CCD detector after subtracting the dark noise.
The detection eﬃciency of subsurface signals was measured
at seven diﬀerent wavelengths in the range from 770 nm to
830 nm. The spectra were acquired in kinetic mode in five sets
of measurements with 40 s used for each acquisition. The
laser power, measured with the power meter after the AOTF
filter was maintained constant at 200 mW at all excitation
wavelengths (the variation of number of photons between
770 nm and 880 nm for the same laser power is around 8%
and as such this diﬀerence was neglected in subsequent analy-
sis considering the magnitude of other eﬀects present).
Regarding the Raman experiments, we have selected three
measurement scenarios taking into account key possible
locations of breast calcifications within living tissue in respect
to illumination in transmission set-up. A trans-stilbene (tS) vial
was placed on front (laser illumination side), middle (inside)
and back (collection side) of the phantom tissue. trans-Stilbene
has a higher Raman scattering cross-section, when compared
to calcium oxalate and hydroxyapatite, although it has similar
optical properties, thus it provides stronger Raman features
with suﬃcient signal to noise ratios avoiding the interference
from artefacts in the background analysis that are easily detect-
able at all vial positions using our setup.30 The laser illumina-
tion position was maintained throughout the vial
repositioning and for all excitation wavelengths.
Data analysis
The recorded Raman spectra were imported into Matlab for
data pre-processing, which consisted of cosmic background
removal and detector intensity oﬀset removal. The ‘peak visi-
bility’ was defined as the ratio between Raman peak height and
the average level of background noise adjacent to the Raman
peak, with the background noise level estimated as a square
root of detected photoelectrons (after appropriate conversion
from CCD counts to photoelectron counts). The peak height
was calculated using Gaussian peak fitting in Origin (Originlab,
Massachusetts, US) after subtracting the local background.
Results and discussion
Fig. 2 presents the attenuation profile of a breast phantom
(porcine tissues) measured using a broad band source,Fig. 1 Transmission Raman set-up.
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coupled to the collection optics used in Raman measurements.
The shorter dimension represents the optical axis in these
experiments and the other dimensions provide semi-infinite
boundaries for the light, thus minimising errors due to losses.
The sample had the same dimensions and composition to the
one used in the Raman measurements, consisting of skin, fat
and protein rich muscle. The attenuation profile is very infor-
mative because it indicates the regions with high attenuation
which needs to be avoided by both laser and Raman photon
wavelengths to minimise photon losses. The spectral region of
minimum absorption is located in the region between 790 and
830 nm, followed by a plateau up to 860 nm and then a steep
slope at around 930 nm.
The relative diﬀerence in attenuations between the lowest
and highest values is about 30%. Therefore, based on the
attenuation profile, we have chosen to explore in detail the
laser excitation wavelengths in the spectral region between
770 nm and 830 nm.
trans-Stilbene [tS] was selected as a local Raman scattering
source for placement at diﬀerent locations in the tissue
phantom. It exhibits stronger Raman scattering compared
with hydroxyapatite providing an easier medium to assess the
influence of laser excitation wavelength on the quality of
Raman signals. It also provides a convenient surrogate for HAP
as its main Raman band is close to the phosphate band of
hydroxyapatite (∼960 cm−1). The results of the Raman
measurements of the tS inside the porcine tissue are presented
in Fig. 2 for each of three locations in the sample. One can
recognize the strong Raman bands of the tS at 997 cm−1 corres-
ponding to ring deformation and C–H deformation at
1195 cm−1.41 The double peak recorded at 1594 cm−1 and
1641 cm−1 belongs to the ring stretching of the aromatic struc-
ture.41 Biological spectral signatures are represented by the C–H
peak between 1420 cm−1 and 1480 cm−1 assigned to protein and
lipid structures present in the sample42 as well as a broad peak
of the proteins around 1342 cm−1. Three Raman peaks of the
trans-stilbene: 997 cm−1, 1195 cm−1 and 1641 cm−1 were ana-
lysed and compared to the background. By choosing more than
one peak, we could monitor the spectral changes of the peaks
throughout the fingerprint region. The contrast between organic
and inorganic structures is very pronounced and helps enable
accurate peak analysis of the trans-stilbene signal penetration.
The inorganic tS vial was placed at three positions in the
sample: between the laser and sample; in the middle of the
sample; between the sample and the collection optics.
The evolution observed in the Raman bands in Fig. 3 is
associated with the diﬀerent interaction of laser photons with
tissue sample molecules in combination with changes in the
sensitivity of the spectrometer system to the Raman photons at
various wavelengths. Furthermore, the vial location within the
tissue also influences the detection of the trans-stilbene peaks.
Also readily noticeable is the absence of the double peaks for
Fig. 3 Raw Raman spectra of the phantom samples (trans-stilbene and
porcine tissue) at seven diﬀerent wavelengths and three measurements
arrangements: (a) vial in the front of the sample; (b) vial in the middle of
the sample; (c) vial in the back of the sample.
Fig. 2 Attenuation proﬁle of porcine tissue block. Red lines are indi-
cation for laser excitation at 800 nm and the corresponding position in
nm of the trans-stilbene Raman peaks at 997 cm−1, 1195 cm−1 and
1641 cm−1.
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the 830 nm excitation when the vial is situated in front of the
tissue on the illumination side.
When the sample is placed in the middle of the tissue
phantom the peaks become more prominent, as the sample is
moved towards the back of the sample on the detection side
the peaks are completely distinguishable. An explanation in
the diﬀerence observed between these three situations may be
found in the attenuation profile (Fig. 2). Because no changes
to the set-up have been made except the vial position, it is the
only parameter that can influence the Raman band heights.
When the sample is placed in front of the tissue the tS Raman
photons are travelling through the tissue towards the detection
side. The corresponding wavelength positions of the Raman tS
bands at 1594 cm−1 and 1641 cm−1 for 830 nm excitation wave-
length are 956 nm and 961 nm; these are well located in the
high attenuation region of the porcine tissue (Fig. 2).
According to the Beer Lambert law, the absorption
increases with the length of sample that light passes through.
Therefore, when the vial in located in the middle the Raman
photons have less distance to travel through the tissue to reach
the collection side and this leads to lower losses and thus
higher numbers of Raman photons collected. Obviously when
the vial is placed at the back of the sample (collection side),
the Raman photons travel immediately into free space and the
collection optics before being detected by the spectrometer,
thus not incurring any associated tissue attenuation of the
Raman photons.
The tS vial positions in respect to tissue location represents
extreme examples of the measurements situations of the
Raman signal sources within tissues, and enable us to assess
the most representative situations relevant to measuring breast
calcification in tissue.
The measurements obtained at diﬀerent excitation laser
wavelengths when the vial is maintained at the same position,
reveal a striking contrast in peak height evolution between
770 nm and 830 nm laser excitation wavelengths (Fig. 3). The
influence of excitation laser wavelength on the Raman signal it
is well known in the scientific community and
documented.43–45 In reality the spectra are influenced not only
by the laser wavelengths used, but also the transmission
profile of the intermediary optics and diﬀraction grating, as
well as the quantum eﬃciency of the CCD detector. The spec-
tral region for Raman detection ranges from 834 nm to
960 nm depending on the laser wavelength and the Raman
bands are located on the descending slope of the quantum
eﬃciency curve of the CCD detector.
That means that detection sensitivity decreases towards
longer excitation wavelength (see ESI Fig. S1†). The corres-
ponding wavelengths of the tS double peaks for the 770 nm
excitation wavelength are 874 nm and 881 nm, and are situated
on the lower attenuation region compared to the same Raman
peaks when using 830 nm excitation (956 nm and 961 nm). In
addition to the absorption and the detection eﬃciency depen-
dencies on wavelength, the Raman scattering cross-section is
also dependent on the laser excitation wavelength, pro-
portional to 1/λ4.
For a clear understanding of the influence of the laser wave-
length on the sensitivity of the detection of Raman bands we
have calculated peak visibility for all three tS peaks. The peak
visibility describes the prominence of Raman bands above the
noise level in the background. Fig. 4 illustrates the average
values of the peak visibility for each sample position corres-
ponding to the selected trans-stilbene peaks plotted against
laser wavelengths. The plots provide a clear picture of the key
parameters of the experiment enabling an advanced under-
standing of the eﬀects of the competing factors combining to
provide an indicator for the optimum laser wavelength. One
can notice a variety of profile trends in each plot and for each
peak individually. Overall the 997 cm−1 peaks tends to have a
smoother evolution compared to the other tS peaks with a
maximum signal reached in the region between 790 nm and
810 nm. The Raman band at 997 cm−1 is close to the peak
positions for calcium oxalate, 945 cm−1 and calcium phos-
Fig. 4 Peak visibility of the trans-stilbene peaks for the all scenarios of
the measurements. Five replicates of each measurement.
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phate 960 cm−1, so it may suitable to choose a laser in this
spectral region.
The other peaks of trans-stilbene indicated distinct behaviours
for each measurement scenario. For the vial located at the front
of the tissue phantom, the peak visibility decreases very steeply
towards longer wavelengths. The vial placed in the middle pres-
ents a diﬀerent picture with 1192 cm−1 for which the peak visi-
bility increases up to 780 nm followed by a steep profile decrease.
The peak at 1641 cm−1 (at a similar spectral position to Amide I
peaks in tissues) indicates a similar profile with an increase up
to 790 nm. The last measurement set-up when the vial is moved
towards the back of the tissue presents a fairly smooth profile for
the 1195 cm−1 peak with a dip at 790 nm and a peak around
810 nm. The profile of the 1641 cm−1 has a more obvious drop
oﬀ, following an increase in peak visibility up to 800 nm, a small
dip at 810 nm followed by a decrease at 830 nm.
To gain insight into the origin of these dependencies we
have performed a more detailed qualitative analysis of the
Raman peaks and background noise level independently.
Fig. 4 depicts the Raman peak heights while Fig. S2 (see ESI†)
presents the corresponding background noise level plots used
for peak visibility calculations. What is interesting about back-
ground noise profiles is that there is a little diﬀerence between
measurements (except Fig. S3c†), the trend of the auto-fluo-
rescence background noise level seems quite linear regardless
of the laser wavelengths. The decreasing profile observed
could be explained by the reduced sensitivity of the CCD detec-
tor towards longer wavelengths.
The Raman peak height (see Fig. 5) indicates the presence
of a trend with excitation wavelength, which was less obvious
in Fig. 4. The overall tendency for each peak height, in the
range of excitations 800–830 nm, is to decrease towards the
longer wavelength regardless of measurement configurations.
Instead we recognize a plateau shape for 997 cm−1 peak height
profile for the laser wavelengths 770 nm, 780 nm and 790 nm
which is diﬃcult to explain since we are expecting a continu-
ous drop in peak height due decrease in signal to Raman scat-
tering cross-section and detector quantum eﬃciency.
Fig. 5 Experimental Raman peak height vs. laser wavelength for each position of the vial [left hand side] inside the tissue along their theoretical
predictions of Raman peak height (right hand side).
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To have a better understanding of the nature of the plateau
shape observed in the plots, we have construct a theoretical
model (eqn (1)) which accounts for a combination of attenu-
ation profile (A), Raman diﬀerential scattering cross section
(dσ/dΩ), instrument response function (R), (symbol “×” rep-
resents multiplication):
F ¼ dσ=dΩ " A " R ð1Þ
We made an assumption that each of these factors will
modify the values of the recorded Raman bands by a scaling
parameter according to each measurement situation. The total
outcome of the model will be a product of these scaling para-
meters that can be applied to the recorded data. For example
when the vial is located in front of the tissue the model will
include the scattering cross-section, instrument response func-
tion and absorption of the Raman photons inside the tissue,
since the laser photons are travelling only in free space prior
to interacting with the tS. The model changes with vial
locations towards the back of the tissue, where the attenuation
of the laser light is more important than the attenuation of
Raman photons. The vial in the middle of the sample model
incorporates both the laser light attenuation and Raman
photon losses. This time the laser photons will be absorbed
and Raman photons are modelled to travel half distance than
at extreme positions. Fig. 6 presents the plots of the two
(997 cm−1 and 1195 cm−1) measured Raman peak intensities
alongside with the computed Raman peak values obtained
from our model overlap in the same plot. For the detailed
picture of the peak comparison experimental vs. simulated the
reader should address the Fig. S5 in ESI.† Overall the simu-
lated plots of the Raman peak intensities tend to follow the
experimental data. The plot profiles change while the vial is
placed at the back (Fig. 5-bottom graphs), indicating a slightly
curved profile between 770 and 790 nm. This is more pro-
nounced in our theoretical results. There is a small potential
diﬀerence in the attenuation profile of the tissue phantom
used Raman and separate attenuation measurements. Depend-
ing on the spectral region on the attenuation and instrument
response function, as well as the vial position relative to the
sample we obtain a diﬀerent outcome of the Raman peak
intensities.
Overall, the simple model provides a satisfactory expla-
nation of data measured. It is therefore viable to derive individ-
ual contributions of each individual factor to the overall
model. In Fig. 6 each parameter included in the theoretical
model along with the overall outcome, for peak 997 cm−1 at
each one of the measurement scenarios are presented. At the
first glance the total profile tends to follow the attenuation
profile in most of the cases. It appears that that tissue attenu-
ation is the dominant eﬀect in our measurements except
Fig. 6c. According to Fig. 6a and c at the laser excitation wave-
Fig. 6 Plot of the individual parameters of the model described from eqn (1): Raman scattering cross-section, instrument’s response function and
tissue attenuation along with overall proﬁle of the model (F) for each vial position front, middle and back.
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lengths 770, 780 and 790 nm we observe competing eﬀects
between instrument response function on one hand and tissue
attenuation and Raman cross-section on the other hand. As a
consequence, these eﬀects balance the contribution of the
attenuation.
For laser excitations between 800 to 830 nm all the plots
seem to indicate a constant decline. We do observe some com-
peting eﬀects again in the Fig. 6c, the attenuation decrease
presents a diﬀerent evolution. The laser absorption seems to
be less influential, for the 997 cm−1 peak when the sample is
placed at the back, so the theoretical profile looks less steep
compared to the other experimental situations. When the vial
containing trans-stilbene (ts) is located at the front or in the
middle of the tissue, the attenuation in the tissue tends to
define the profile of the plots since it drops faster than other
parameters.
Conclusions
In this paper, we explored the Raman peak visibility of a
‘foreign’ sample, mimicking breast calcifications, in trans-
mission Raman spectroscopy located in front, middle and
back of a thick porcine phantom tissue at seven diﬀerent exci-
tation wavelengths. The Raman measurements indicate the
strong influence on sample position, instrument response
function and laser excitation wavelength on the peak visibility.
The peak visibility plots provide a comprehensive picture
about detection sensitivity of the transmission Raman set-up
at diﬀerent wavelengths. We conclude that the optimum laser
wavelength for breast calcification detection lies in the spectral
region between 790 and 810 nm.
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